United Therapeutics (UTHR) Capital Expenditures (2009 - 2026)
United Therapeutics (UTHR) posted Capital Expenditures of $99.6 million for Q1 2026, up 143.06% sequentially from -$231.3 million in Q4 2025, and up 32.98% YoY from $74.9 million in Q1 2025.
United Therapeutics (UTHR) Capital Expenditures (2009 - 2026) Analysis & Trends
United Therapeutics has reported Capital Expenditures for 18 years, with the latest figure at $99.6 million in Q1 2026.
- Quarterly Capital Expenditures rose 32.98% year-over-year to $99.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $141.0 million (down 52.65% YoY) and the FY2025 annual result came in at $116.3 million, down 52.82% from the prior year.
- Capital Expenditures grew to $99.6 million in Q1 2026 per UTHR's latest filing, from -$231.3 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $281.4 million in Q3 2025 and troughed at -$231.3 million in Q4 2025.
- A 5-year average of $29.1 million and a median of $18.4 million in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 1044.44% in 2022, then slumped 2442.86% in 2023.
- Over 5 years, Capital Expenditures stood at $700000.0 in 2022, then plunged by 2442.86% to -$16.4 million in 2023, then jumped by 628.66% to $86.7 million in 2024, then plunged by 366.78% to -$231.3 million in 2025, then jumped by 143.06% to $99.6 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $99.6 million, -$231.3 million, and $281.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 8.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.00 Mn |
| Jun 30, 2026 | 108.00 Mn |
| Mar 31, 2026 | 99.60 Mn |
| Mar 31, 2026 | 99.60 Mn |
| Dec 31, 2025 | -231.30 Mn |
| Dec 31, 2025 | -231.30 Mn |
| Sep 30, 2025 | 281.40 Mn |
| Sep 30, 2025 | 281.40 Mn |
| Jun 30, 2025 | -8.70 Mn |
| Jun 30, 2025 | -8.70 Mn |
| Mar 31, 2025 | 74.90 Mn |
| Mar 31, 2025 | 74.90 Mn |
| Dec 31, 2024 | 86.70 Mn |
| Dec 31, 2024 | 86.70 Mn |
| Sep 30, 2024 | 76.50 Mn |
| Sep 30, 2024 | 76.50 Mn |
| Jun 30, 2024 | 59.70 Mn |
| Jun 30, 2024 | 59.70 Mn |
| Mar 31, 2024 | 23.60 Mn |
| Mar 31, 2024 | 23.60 Mn |